Promising research on the susceptibility to and drug targets for Parkinson's disease

Better understanding of Parkinson’s disease onset during aging is important for improving diagnostics and developing strategies for therapeutic intervention. Scientists from the University Medical Center in Groningen have now identified genes and processes that may underlie what makes some people more susceptible to this disease. Their findings are described in an article published March 21 in the open-access journal PLoS Genetics.

On average, the population of the western world is living longer, resulting in an increased number of people with age-related neurological conditions, including Alzheimer’s and Parkinson’s disease. A cure for these diseases remains elusive because their molecular cause is only partially understood. It has been noted, however, that accumulations of folded proteins are commonly found within the brain cells of those who suffer from these diseases. For this reason “protein misfolding” seems to form the basis of these diseases.

To gain insight into the cellular processes that play a role in protein misfolding, the research group, led by Ellen Nollen, looked for genes in the round worm Caenorhabditis elegans that, if switched off, cause the number of inclusions to increase. During the course of their research, the scientists individually switched off 17,000 of the 19,000 genes and studied the effect on protein formation.

The study findings indicate that the gene sir-2.1 has a considerable effect on protein formation. In humans, this gene, called SIRT1, is evolutionarily conserved and is involved in the aging of yeast, flies, and worms and probably also in mammals. It lengthens the lifespan of worms by the activation of various routes through which signals are transmitted (stress response and insulin signal transduction). These findings suggest that sir 2.1 may represent a possible mechanistic relationship between aging and Parkinson's disease.

The accumulation of proteins has been shown to be strongly age-dependent and to occur in clearly distinguishable phases. From RNA-interference screening, it appears that the manner in which proteins accumulate in the roundworm model can be clearly differentiated from that of other diseases in which the aggregation of proteins occurs. Moreover, it shows a clear link with the aging process, in which the membranes of the endoplasmatic reticulum/Golgi system of the cell probably play a role. This study points the way towards further clarification of the pathological mechanisms of, and the genetic susceptibility to, Parkinson's disease and other conditions in which the disease-specific protein alpha-synuclein plays a role.

Citation: van Ham TJ, Thijssen KL, Breitling R, Hofstra RMW, Plasterk RHA, et al. (2008) C. elegans Model Identifies Genetic Modifiers of a-Synuclein Inclusion Formation During Aging. PLoS Genet 4(3): e1000027. doi:10.1371/journal.pgen.1000027

Source: Public Library of Science

Related stories:

Increased level of magnetic iron oxides found in Alzheimer's disease
A team of scientists, led by Professor Jon Dobson, of Keele University in Staffordshire, UK, have found, for the first time, raised levels of magnetic iron oxides in the part of the brain affected by Alzheimer's Disease (AD).
Out-of-whack protein may boost Parkinson's
A single change in a protein may play a role in whether someone develops Parkinson’s disease, say University of Florida Genetics Institute researchers writing in a recent issue of the Proceedings of the National Academy of Sciences.
New pathway provides more clues about BRCA1 role in breast cancer
A breast cancer gene's newly discovered role in repairing damaged DNA may help explain why women who inherit a mutated copy of the gene are at increased risk for developing both breast and ovarian cancer.
Overexcited neurons not good for cell health
Neurotransmitters have consequences. They initiate events that are critical to a healthy life, giving us the ability to move, to talk, to breathe, to think. But that’s if the neurotransmitters are getting it right and sending proper signals downstream to muscle cells, neurons or other cells.
Study identifies novel Parkinson's disease drug target
Researchers at the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) have identified a potential new drug target for the treatment of Parkinson’s disease and possibly for other degenerative neurological disorders.
New research implicates myelin in early evolution of Huntington's disease
Last month, Dr. George Bartzokis, director of the UCLA Memory Disorders and Alzheimer’s Disease Clinic, suggested in the journal Alzheimer’s & Dementia that the breakdown of a type of myelin that develops late in life promotes the buildup of toxic amyloid plaques long associated with Alzheimer’s disease. Myelin is the “insulation” that wraps around nerve axons in the brain.
Good for the goose, not so great for the gander
A provocative new model proposed by molecular biologist John Tower of the University of Southern California may help answer an enduring scientific question: Why do women tend to live longer than men? That tendency holds true in humans and many other mammals as well as in the much-studied fruit fly Drosophila melanogaster.
Families of contaminated heparin victims tell stories of deaths
(AP) -- The widow of a man who died after receiving contaminated heparin told a congressional subcommittee Tuesday "we have a false sense of security" in a land where people expect to be protected and safe.

News discussion:

Medicine & Health news